View allAll Photos Tagged FDA
Feb. 5, 2009; Irvine, CA – An FDA microbiologist tests seafood samples for the presence of Salmonella. To learn more about how FDA is helping to ensure seafood safety, read these Consumer Updates:
Fish Hazards and Controls: More Than a Fish Story
www.fda.gov/ForConsumers/ConsumerUpdates/ucm257816.htm
How FDA Regulates Seafood: FDA Detains Imports of Farm-Raised Chinese Seafood
www.fda.gov/ForConsumers/ConsumerUpdates/ucm094558.htm
FDA photo by Michael J. Ermarth
Feb. 5, 2009; Irvine, CA – An FDA microbiologist working in a biosafety laboratory tests for high risk pathogens in food. For more about food and food safety, see these FDA Consumer Updates:
www.fda.gov/ForConsumers/ConsumerUpdates/ucm149202.htm
This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth
The Know Your Source FDA program:
The number of Rogue Wholesale Drug Distributors selling fake or unapproved prescription drugs in the U.S. market is growing...
The U.S. Food and Drug Administration warned that doctors need to:
* be vigilant when purchasing medicines
* verify that their supplier is licensed by the state
* know the source for prescription drugs.
Sources and more information:
* Know Your Source: Protecting Patients from Unsafe Drugs, FDA ucm389121, 09/23/2014 .
* Reducing the Threat of Counterfeit and Unapproved Drugs in Clinical Settings, brookings, 2013/07/19.
In the late summer of 1957, Harrison Laboratories unleashed their new cosmetic product, TenDay Press-On Nail Polish—a fingernail-shaped red plastic strip with a white adhesive backing that was meant to be directly fastened to the consumer’s natural nails. Harrison launched the commercial debut of its new product with a massive advertising campaign that took advantage of the 1950s boom in television ownership. Over the course of two- and-a- half weeks, it broadcast no less than 110 television ads that promised consumers luxurious, long, natural-looking nails while strengthening weak nails! Harrison Lab’s PR gambit paid off handsomely. After just two weeks on the market, the company reportedly collected about $200,000 in sales from its new product.
But while the advertising worked, the product did not. Throughout the fall, FDA received at least 700 consumer complaints reporting that the press-on nails were causing nail injuries, including peeling, thinning, cracking, and splitting the nail enamel. In the worst cases, user’s nails split down to their cuticles or broke off, leaving their nail beds exposed and inhibiting the normal use of their hands.
In early 1958, FDA took legal action against TenDay Press-On Nail Polish, alleging libel in a case filed in federal court in Maryland. The agency also issued a public warning alerting consumers to the risk of injury associated with the faux nails and began seizing stocks of the product across the country. Even before the court returned a verdict, Harrison Labs agreed to withdraw the product from the market and accept returns rather than contest FDA’s seizure actions. By late May, the court affirmed FDA’s claim and ordered that all seized products be destroyed. Harrison Labs subsequently issued a nationwide recall of what remained of the 32 million units it had distributed. Within a few short months, this briefly celebrated, but recklessly dangerous, cosmetic had been “rooted out” of commerce thanks to FDA’s swift response to engaged consumers. Today, FDA continues to regulate nail care products under the Federal Food Drug and Cosmetic Act, and educates the public about these products through consumer updates (go.usa.gov/xRezK).
In the late summer of 1957, Harrison Laboratories unleashed their new cosmetic product, TenDay Press-On Nail Polish—a fingernail-shaped red plastic strip with a white adhesive backing that was meant to be directly fastened to the consumer’s natural nails. Harrison launched the commercial debut of its new product with a massive advertising campaign that took advantage of the 1950s boom in television ownership. Over the course of two- and-a- half weeks, it broadcast no less than 110 television ads that promised consumers luxurious, long, natural-looking nails while strengthening weak nails! Harrison Lab’s PR gambit paid off handsomely. After just two weeks on the market, the company reportedly collected about $200,000 in sales from its new product.
But while the advertising worked, the product did not. Throughout the fall, FDA received at least 700 consumer complaints reporting that the press-on nails were causing nail injuries, including peeling, thinning, cracking, and splitting the nail enamel. In the worst cases, user’s nails split down to their cuticles or broke off, leaving their nail beds exposed and inhibiting the normal use of their hands.
In early 1958, FDA took legal action against TenDay Press-On Nail Polish, alleging libel in a case filed in federal court in Maryland. The agency also issued a public warning alerting consumers to the risk of injury associated with the faux nails and began seizing stocks of the product across the country. Even before the court returned a verdict, Harrison Labs agreed to withdraw the product from the market and accept returns rather than contest FDA’s seizure actions. By late May, the court affirmed FDA’s claim and ordered that all seized products be destroyed. Harrison Labs subsequently issued a nationwide recall of what remained of the 32 million units it had distributed. Within a few short months, this briefly celebrated, but recklessly dangerous, cosmetic had been “rooted out” of commerce thanks to FDA’s swift response to engaged consumers. Today, FDA continues to regulate nail care products under the Federal Food Drug and Cosmetic Act, and educates the public about these products through consumer updates (go.usa.gov/xRezK).
The U.S. Food and Drug Administration (FDA) is a science-based regulatory agency working to protect the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation's food supply, cosmetics, and products that emit radiation.
This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required.
Historians Dr. Suzanne Junod and Dr. John P. Swann care for thousands of artifacts at FDA, including (left to right) “Placebo Inhalation Powder,” an inert treatment that admitted to being therapeutically worthless in its name; “Pep-Ti-Kon,” a health tonic containing lots of alcohol; and a model of a “Zerret Applicator,” a 1940s-era device that (falsely) promised to relieve suffering from any known disease. For more information read this FDA Consumer Update:
FDA Historians Share Lessons From Agency's Past
This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth
Dan Berger is Cartoonist behind Natural News.
" ...The Food and Drug Administration, an agency that suffers under the hallucination that it protects the public from dangerous foods and drugs, has actually become the marketing department of Big Pharma. It actually takes money from drug companies in exchange for evaluating and approving their drugs, and the decisions concerning which drugs to approve almost always come down to a panel of "experts" who have strong financial ties to the very companies impacted by their decisions..."
... continue reading: FDA vision test, by Mike Adams, the Health Ranger.
All our posts about big pharma, drugs, DrugMoney, the FDA.
See more comics...
The main entrance of FDA Building 1, which houses the Commissioner’s and Senior Staff’s offices. The FDA campus is located at 10903 New Hampshire Ave., Silver Spring, MD 20993.
This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. Privacy and use information: www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth
The FDA inspector had to be prepared with an array of sampling, measuring, and recording equipment.
For more information about FDA history visit www.fda.gov/AboutFDA/WhatWeDo/History/default.htm
On March 5, 2018, FDA Commissioner Scott Gottlieb, Senator Michael Burgess, and others toured the International Mail Facility in New York. There they saw firsthand the massive volume of imports that are reviewed daily. More than 340 million packages are sent to the U.S. every year through the International Mail Facilities. FDA staff at these facilities play a critical role in helping ensure they don’t contain counterfeit, unapproved or dangerous products.
FDA recently tripled the number of staff at the International Mail Facilities to improve our ability to inspect packages that are suspected of having drugs. This front-line work is critical to FDA’s ability to protect the public health, but more work remains. The FDA is seeking certain administrative steps to expand the strength of our regulatory oversight and may seek some additional, limited resources and authorities from Congress. FDA is also working closely with our partners at CBP and USPS as part of a new working group.
These photos are free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required.
Privacy and Use Information:
www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth
The blue words are how the FDA tells the pet food recall story. The red words are how it really went down.
Oscilloclast: Dr. Albert Abrams claimed that electrons were the “basic biological unit” and disease was a “disharmony of electronic oscillations in the body.” He invented a machine which supposedly played back electronic waves into the body thus “creating harmony and curing the body from disease.” FDA prosecuted Abrams during the 1950s.
For more information about FDA history visit www.fda.gov/AboutFDA/WhatWeDo/History/default.htm
This 2013 cartoon by Mac from The Daily Mail related to the 2013 news that female Viagra that boosts a woman’s sex drive could be on the market within three years...
* Read Will the “female Viagra” really help women? and watch Flibanserin “Female Viagra” gets approval from FDA with conditions: theDESK video.
* See more health cartoons.
The U.S. Food and Drug Administration (FDA) is a science-based regulatory agency working to protect the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation's food supply, cosmetics, and products that emit radiation.
This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required.
The U.S. Food and Drug Administration (FDA) is a science-based regulatory agency working to protect the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation's food supply, cosmetics, and products that emit radiation.
This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required.
The U.S. Food and Drug Administration (FDA) is a science-based regulatory agency working to protect the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation's food supply, cosmetics, and products that emit radiation.
This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required.